You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 108 No. 6, Dec 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (35)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chloroma and Related Myeloblastic Neoplasms

GEORGE REARDON, M.D.; WILLIAM C. MOLONEY, M.D.

Arch Intern Med. 1961;108(6):864-871.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Chloroma, a malignant green tumor arising from myeloid tissue, was first described in 1823, and subsequently some 350 cases have been reported in the literature.1,2 Early case reports described chloroma as a green tumor occurring predominantly about the skull, particularly in the orbital region, and usually found in infants or children with acute leukemia. For many years chloroma was associated with leukemia of various cell types, but it is now apparent that chloroma is related only to myelogenous leukemia and that it may occur anywhere in the body in old as well as young patients. Tumor masses histologically identical to chloroma but without greenish pigmentation have been described in patients with myelogenous leukemia. In other instances patients were found at autopsy to have greenish discoloration of many organs, tissues, and even body fluids; however, in these cases tumor masses, green or otherwise, could not be identified.

In describing myeloblastic . . . [Full Text PDF of this Article]


Author Affiliations

BOSTON

From Hematology Laboratory (Tufts), Boston City Hospital, and Department of Medicine, Tufts University Medical School.


Footnotes

Submitted for publication Nov. 15, 1960.

This work was carried out as part of an investigation supported by A.E.C. Grant No. AT (30-1) 1871 and N.I.H. Grant CY 4724.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.